
Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation
Author(s) -
R. Servais,
Mahmoud Ammar,
Payal Gurnani
Publication year - 2019
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-229612
Subject(s) - medicine , extracorporeal membrane oxygenation , ards , blastomycosis , acute respiratory distress , amphotericin b , dosing , extracorporeal , intensive care medicine , lung , antifungal , surgery , dermatology
Blastomycosis-associated acute respiratory distress syndrome (ARDS) has a rare incidence. We report the case of a 29-year-old man with blastomycosis-associated ARDS receiving extracorporeal membrane oxygenation and managed with high-dose liposomal amphotericin B. This case illustrates the importance of timely diagnosis of pulmonary blastomycosis and appropriate dosing of antifungal therapy.